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ADCAbstract MRI is becoming an essential tool for assessment of breast pathology. Diffusion
weighted imaging (DWI) provides quantitative and qualitative information reflecting the changes
in tissue cellularity and integrity of cell membranes.
Objective: To assess the diagnostic importance of ADC numerical value and ratio in the differen-
tiation between benign and malignant breast masses.
Patients and methods: The study included 37 patients with solitary solid breast mass. DWI was
acquired at b-value 0–600. ADC value and ADC ratio were calculated and the values were corre-
lated to histopathology.
Results: Sixteen out of 37 detected masses were malignant and 21 were benign. Malignant lesions
showed lower ADC values than benign lesions. The ROC study revealed that a cutoff ADC value of
1.175  103 mm2/s had high sensitivity of 95.2% and specificity of 93.8% in the differentiation
between benign and malignant breast lesions. Malignant lesions showed lower ADC ratio than
benign lesions. A cutoff value for ADC ratio of 0.9 had moderate sensitivity of 73.7% and high
specificity of 100% in the differentiation between benign and malignant lesions.
Conclusion: DWI can differentiate between benign and malignant breast lesions with high sensitiv-
ity and specificity.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.
org/licenses/by-nc-nd/4.0/).1. Introduction
Magnetic resonance imaging (MRI) is gaining wide spread
acceptance as an essential tool for examination of breast
pathology. In comparison with ultrasound andmammography,it has high sensitivity due to the use of contrast enhancement
material (1–3). Dynamic gadolinium contrast enhanced mag-
netic resonance imaging (DCE-MR) was found to have high
sensitivity (>90%) and moderate specificity (85%) as
demonstrated by multi-center trials (4,5); however, there is con-
founding overlap between benign and malignant lesions on
some occasions, making the distinction a rather difficult task
on the basis of conventional MRI features (6,7). Diffusion-
weighted imaging (DWI) is an advanced MRI technique that
derives its image contrast from variation of water molecules
Table 1 Distribution of masses according to cytological
and/or histopathological types or follow-up.
Type of the lesion No. of cases
Invasive ductal carcinoma 8
Lobular carcinoma 7
Malignant Paget’s disease 1
Fibroadenoma 11
Lactating adenoma 2
Hamartoma 1
Papilloma 1
Tuberculous granuloma 1
Granulomatous intramammary lymph node 1
Benign mass (follow-up more than one year) 4
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related to the tumor cellularity and integrity of cell membranes.
Both qualitative and quantitative assessment can be made, and
the latter is achieved through measuring the apparent diffusion
coefficient (ADC), that is directly proportional to the water dif-
fusion in the tissue (8). We aimed in this study to assess the
diagnostic importance of ADC numerical value and ratio in
the differentiation between benign and malignant breast
masses.
2. Patients and methods
2.1. Study design and sample
A prospective study was conducted at the MRI unit at
AL-Emamain Alkadhimain medical city/Baghdad during the
period from May 2014 through December 2014. Initially a
total of 44 female patients were examined by MRI. Later on
7 patients were excluded and only 37 patients constituted the
study sample. The patients were recruited from the breast
clinic at the same medical center following the detection of
breast mass by other imaging modalities (ultrasound (US),
mammography (MG)). Written informed consent was
obtained from all patients to participate in the study. Only
those patients who were found to have solitary breast mass
were further evaluated by conventional MRI and DWI.
Lesions were included in the study if benign or malignant out-
come could be definitively confirmed through tissue acquisi-
tion or the lesions confirmed to be of benign nature by
previous examinations (US, MG and/or MRI) with no signif-
icant modification in the size or characters for more than
1 year duration. The demographic criteria and relevant clinical
history were recorded as well as current and prior breast imag-
ing findings (US/MG mammography and BIRADS category).
Then the patients were referred to the MRI unit (after exclu-
sion of any contraindications for the examination). Conven-
tional DWI was performed and the findings were analyzed.
The histopathological results for the lesions under study were
obtained later. Seven patients out of 44 patients were excluded
from the study after MRI either because the mass found to be
complicated cyst, nonvisualization of the lesion by DWI
mainly related to its small size (less than 1 cm), or because
the DW-MRI sequences did not have diagnostic quality due
to motion artifact, nonmass like enhancement due to diffuse
tumor spread and difficult to obtain ROI measurement due
to partial volume effect or due to loss of follow-up, leaving
only 37 patients to represent the study sample.
2.2. MRI protocol and data analysis
The images were acquired with a 1.5-T MRI scanner (PHI-
LIPS ACHIEVA MEDICAL SYSTEM) using bilateral single
breast coil. The conventional MRI sequences performed
included T1 W sequence axial section and T2 W sequence axial
section, and five continuous dynamic_Ethrive contrast-
enhanced acquisitions in axial sections were performed using
Magnaevist 0.5 mmol/ml (dimeglumine gadopentetate), and
the dose given was 0.2 mmol/kg body weight administered
by intravenous rout. All the diffusion weighted images were
obtained by echoplanar imaging (EPI) sequence with single
shot at b value (0, 600), TR/TE: 1000/82, FOV: 340 mm, slicethickness: 3 mm, and total scan duration: 3:24:1 min. The
images were transferred to a workstation for processing.
The ADC values were calculated automatically by placing
the region of interest (ROI) within the confines of the
lesions. The reference image was obtained from the contrast-
enhanced images as the latter had better resolution. The
enhanced part of the lesion was selected for evaluation on
the corresponding DW-MRI. The scanner software provides
the mean value within the ROI, which equals the ADC value
(multiplied by 103). The area of the ROI ranged from 24 to
88 mm2 (the mean: 53.38 ± 10.87 SD) according to the size
of the lesions. Apparent necrotic or cystic components were
avoided by referring to conventional MR images. For lesions
less than 2 cm in diameter, one circular region was measured
as the ROI and for lesions larger than 2 cm three areas were
measured in different places and their average values were
obtained.
Measurement of ADC ratio was obtained after measuring
the ADC value of the fibroglandular tissue at the normal con-
tralateral side, which is equal to lesion ADC/fibroglandular
ADC.
3. Statistical analysis
T-test statistical study was used for statistical analysis of the
data comparing the mean ADC values and ADC ratio between
benign and malignant breast masses with reference to the
Histopathological or follow-up data. A p value <0.05 was
considered significant. Receiver operating characteristic
(ROC) curve statistical study used for presentation of data
and the optimal cutoff levels for differentiating benign versus
malignant lesions were determined by identifying the points
where the sensitivity and specificity were equal on the ROC
curves. According to ROC analyses, the sensitivities and speci-
ficities of ADC value and ADC ratio were obtained.
4. Results
A total number of 37 patients were enrolled in this study, and
the age range was 17–83 years (mean = 42 years ± 17.49).
Twenty-one of the masses were benign and 16 were malignant.
The histopathological types of malignant masses (N= 16) are
represented in Table 1. Seventeen out of 21 benign masses were
proved by histopathology, and the other 4 lesions were classi-
fied as BI-RADS 2 category by U/S and/or mammography
Diffusion weighted MRI 1339with no significant change in the imaging patterns of these
lesions over one year period of follow-up with mammography
and/or sonogram (Table 1).
The range of ADC values for malignant breast lesions
(N= 16) was 0.65–1.46  103 mm2/s and the median was
0.93  103 mm2/s. The range of ADC value for benign breast
lesions was 1.11–1.86  103 mm2/s and the median was
1.51  103 mm2/s (Fig. 1).
The ADC values obtained from malignant breast lesions
range from 0.65 to 1.46  103 mm2/s, and mean was 0.94 ±
0.2  103 mm2/s with 15 lesions having ADC value equal or
less than 1.1  103 mm2/s; these values were significantly
lower than those observed in benign lesions which ranged from
1.11 to 1.86  103 mm2/s, and mean was 1.5 ±
0.17  103 mm2/s with 20 lesions showing ADC values equal
or more than 1.3  103 mm2/s, p value <0.0001 (Table 2).
Only one of 16 malignant lesions (malignant Paget’s dis-
ease) showed high ADC value (1.46  103 mm2/s); on the
other hand one of the 21 benign lesions (papilloma) showed
low ADC value measures (1.1  103 mm2/s). Regarding
malignant lesions minimum ADC value was obtained in inva-
sive ductal carcinoma stage 3 and the highest ADC value was
obtained in malignant Paget’s disease. For benign lesions min-
imum ADC value was noted for papilloma while the highest
ADC value was reported for tuberculous granuloma. Compar-
ing the ADC values of different pathologies noted that
fibroadenoma (no = 11) had significantly higher ADC value
range (1.5–1.7  103 mm2/s, mean 1.58  103 mm2/s ±
0.08) than ductal and lobular carcinoma (no = 15).
Comparing the malignant breast tumors, ductal carcinoma
(no = 8) was found to have mildly lower ADC value range
(0.65–1.08  103 mm2/s, mean 0.84  103 mm2/s ± 0.14)
than lobular carcinoma (no = 7) (range 0.77–1.15 
103 mm2/s, mean 1.00  103 mm2/s ± 0.12).
ROC statistical analysis study was used for presentation of
data and measure of cutoff point ADC value between benign
and malignant breast lesions. The ROC study reveals that a
cutoff ADC value (1.175  10–3 mm2/s) had high sensitivity
of 95.2% and specificity of 93.8% in the differentiation
between benign and malignant breast lesions (p value
<0.001) (Fig. 2).Fig. 1 Box plot graph of ADC for benign (n= 21) and
malignant (n= 16) breast lesions.The mean ADC values for normal fibroglandular tissue
were 1.363 mm2/s ± 0.3 SD, and range was 1.24–1.79  103
mm2/ s. Malignant masses showed ADC ratio range of 0.46–
0.91 and the mean was 0.7 ± 0.18; these results were signifi-
cantly lower than those of benign masses that showed ADC
ratio range of 0.67–1.25 and the mean was 1.02 ± 0.15, p value
<0.0004 (Table 3).
ROC study revealed that a cutoff ADC ratio 0.9 had a high
sensitivity and specificity in the differentiation between benign
and malignant breast lesions that is 73.7% and 100% respec-
tively (Fig. 3).
By comparing ADC value and ADC ratio for all the
lesions, the current study showed that in both methods of mea-
surement there are significant differences between benign and
malignant lesions, p value <0.0001 and 0.0004 respectively.
In addition both ADC ratio and ADC value had high sensitiv-
ity and specificity in the differentiation between benign and
malignant breast lesions (p value <0.001 for both). The
ADC ratio had more specificity but lower sensitivity than
ADC value.5. Discussion
Despite the improvement in the detection of breast cancer with
the widespread application of mammography and ultrasound,
breast lesions still remain difficult to diagnose and character-
ize, especially in dense fibroglandular breasts. The main advan-
tage of MRI in the breast is that they can improve the
detection and characterization of multiple and/or small lesions
even in the dense fibroglandular breasts (9). However, the
moderate specificity of conventional MRI remains a problem
(3,4).
In recent years, the DWI has been extensively applied in
evaluating cerebral tumors and the correlation between the
ADC value and the cellular density has been verified. Briefly,
the higher the cellular density is, the lower the ADC value will
be in DWI, and vice versa (10). For malignant tumors, they
have a relatively high cellular density and therefore will pro-
duce a low ADC value in DWI, while for benign lesion, its
density is generally low and thus will produce a high ADC
value in DWI. Application of DWI in the diagnosis of breast
lesions has been reported recently (11–14).
In the current study the mean ADC value of malignant
breast tumors (higher cellularity tumors) was significantly
lower than that of benign breast tumors (lower cellularity
tumors), using a cutoff value of 1.17  10–3 mm2/s and the sen-
sitivity and specificity of as high as 95.2% and 93.8% respec-
tively (p value <0.001) in the differentiation between benign
and malignant breast lesions. These results were in agreement
with those of Pereira et al. (15) who showed that the mean
ADC value of breast tumors correlates well with tumor cellu-
larity and that malignant breast tumors have a higher cellular-
ity and a lower ADC value than benign breast tumors, and
they proposed that a cutoff ADC value of 1.24  10–3 mm2/s
had sensitivity and specificity of as high as 92% and 96%,
respectively, for the differentiation between benign and malig-
nant lesions.
Other Prior studies with breast MRI and DWI have shown
promising results in differentiating benign and malignant
lesions, with sensitivity ranging from 81% to 93% and speci-
ficity from 80% to 88.5% (16–20).
Table 2 Comparison of ADC value between benign and malignant lesions by t test.
Parameter Benign N= 21 range Benign mean ± SD Malignant N= 16 range Malignant mean ± SD P value
ADC (103 mm2/s) 1.11–1.86 1.5 ± 0.17 0.65–1.46 0.94 ± 0.2 <0.0001
Fig. 2 ROC curve for ADC value of benign and malignant
breast lesions.
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ADC) also had high sensitivity and specificity (73.7% and
100% respectively) in the differentiation between benign and
malignant breast lesions, p value <0.001 and in comparison
with same lesions sample ADC value which revealed sensitivity
and specificity of 95.2% and 93.8% respectively, p value
<0.001, we noted that the ADC ratio is less sensitive but more
specific than ADC value, so that adding ADC ratio to ADC
value can increase the specificity of the breast DWI in the diag-
nosis; however, measurement of ADC ratio has some limited
application when dealing with fatty breast where no fibroglan-
dular tissue can be recognized. Our results were in agreement
with Hirano et al. study (21), who showed the sensitivity and
specificity of ADC ratio in the diagnosis of benign and malig-
nant lesions to be 70.1% and 70.1% respectively while Sahin &
Aribal (22) showed that a threshold ADC ratio of 0.8 had
91.4% sensitivity and 100% specificity in the diagnosis of
breast lesions.
In the current study, one out of 16 malignant lesions
(malignant Paget’s disease) showed high ADC value measuresTable 3 Comparison of ADC ratio between benign and malignant
Parameter Benign N= 21 range Benign mean ± SD M
ADC ratio 0.67–1.25 1.02 ± 0.15 01.46  103 mm2/s. The possible explanation may be related to
the histopathologic features of the lesion which showed abun-
dant pale cytoplasm that often contains mucinous material so
more the molecular motion and higher the ADC value. On the
other hand the only case of duct papilloma from benign lesions
encountered in this study showed low ADC value of
1.1  103 mm2/s and this was possibly due to high cellularity
of the tumor so more the restriction in the molecular motion
and lower the ADC value. Kawashima et al. (23) and
Hatakenaka et al. (24) concluded that a carcinoma with a very
high signal intensity on T2-weighted images such as mucinous
colloid carcinoma resulted in misleading ADC values because
of a lower cell density and higher extracellular water content.
Furthermore Guangwei et al. (25) and Woodhams et al.
(26) also reported that most intraductal papilloma had low
ADC values.
Pereira et al. (15) showed that a malignant tumor with low
cellularity, such as the malignant phyllodes tumor with cystic
areas shows high ADC value, consequently was misdiagnosed
as benign, Conversely, a benign tumor with high cellularity,
such as the papilloma showed low ADC and led to the misdi-
agnosis of malignancy.
According to the ADC values, all fibroadenomas and inva-
sive carcinomas were appropriately classified. These indicate
that ADC would be effective in the distinction between
fibroadenomas and invasive carcinomas. This should be help-
ful in lesion characterization because fibroadenomas are
known to have characteristics that overlap with malignant
lesions in both ultrasound and dynamic contrast-enhanced
MRI studies (27–29).
Pereira et al. (15) also showed that there is significant differ-
ence in ADC value of fibroadenoma and invasive carcinoma.
In the current study it has been found that even different
types of malignant breast lesions had low but different ADC
values, and invasive ductal carcinoma showed lower ADC
value than lobular carcinoma that probably related to degree
of invasiveness and cellularity as the more invasiveness of
the tumor, the more the cellularity, the more the restriction
and the lower the ADC value. Hatakenaka et al. reported an
inverse correlation between ADC value and tumor cellularity
(24).
In conclusion, DW MRI of the breast and ADC value are
sensitive and specific parameters that can help to differentiate
benign and malignant breast lesions. DWI of the breast pro-
vides additional information to characterize focal breastlesions by t test.
alignant N= 16 range Malignant mean ± SD P value
.46–0.91 0.7 ± 0.18 <0.0004
Fig. 3 ROC curve for ADC ratio between benign and malignant
breast lesions.
Diffusion weighted MRI 1341lesions in a fast and easy way and will hopefully help to reduce
invasive procedures.
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